Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail V Sitkovsky

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|February 5, 2003
Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivoMichail V Sitkovsky
Cancer Discovery|January 11, 2020
Lessons from the A2A Adenosine Receptor Antagonist-Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell CancerMichail V Sitkovsky
Current Opinion in Pharmacology|August 31, 2020
Sufficient numbers of anti-tumor T cells is a condition of maximal efficacy of anti-hypoxia-A2-adenosinergic drugs during cancer immunotherapyMichail V Sitkovsky
Trends in Immunology|February 10, 2009
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune responseMichail V Sitkovsky
Blood|August 30, 2003
Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivoGregorio Gomez, Michail V Sitkovsky
Trends in Immunology|June 1, 2005
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?Michail V Sitkovsky, Akio Ohta
The Journal of Biological Chemistry|October 8, 2010
Adenosine A2A receptor is involved in cell surface expression of A2B receptorKengo Moriyama, Michail V Sitkovsky
The International Journal of Biochemistry & Cell Biology|February 5, 2003
Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivoGregorio Gomez, Michail V Sitkovsky
The Journal of Clinical Investigation|September 2, 2020
Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapyStephen M Hatfield, Michail V Sitkovsky
Current Pharmaceutical Design|July 23, 2003
HIF-1 alpha deficiency perturbs T and B cell functionsHidefumi Kojima, Michail V Sitkovsky, Marilia Cascalho
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|February 5, 2003
Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivoMichail V Sitkovsky
Cancer Discovery|January 11, 2020
Lessons from the A2A Adenosine Receptor Antagonist-Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell CancerMichail V Sitkovsky
Current Opinion in Pharmacology|August 31, 2020
Sufficient numbers of anti-tumor T cells is a condition of maximal efficacy of anti-hypoxia-A2-adenosinergic drugs during cancer immunotherapyMichail V Sitkovsky
Trends in Immunology|February 10, 2009
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune responseMichail V Sitkovsky
Blood|August 30, 2003
Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivoGregorio Gomez, Michail V Sitkovsky
Trends in Immunology|June 1, 2005
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?Michail V Sitkovsky, Akio Ohta
The Journal of Biological Chemistry|October 8, 2010
Adenosine A2A receptor is involved in cell surface expression of A2B receptorKengo Moriyama, Michail V Sitkovsky
The International Journal of Biochemistry & Cell Biology|February 5, 2003
Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivoGregorio Gomez, Michail V Sitkovsky
The Journal of Clinical Investigation|September 2, 2020
Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapyStephen M Hatfield, Michail V Sitkovsky
Current Pharmaceutical Design|July 23, 2003
HIF-1 alpha deficiency perturbs T and B cell functionsHidefumi Kojima, Michail V Sitkovsky, Marilia Cascalho
Pageof 4